New: A brand-new, unused, unopened and undamaged item in original retail packaging (where packaging is ... Read moreabout the condition
|Brand:||Jobe||MPN:||Does Not Apply|
|Colour:||Blue||EAN:||does not apply|
- Vans Style 112 Brown Navy Men's Size 9 (woman's 10.5)
- ALPS Mountaineering Rendezvous Chair, Rust
- Brand NEW Camo Hoyt Pro Defiant 34 Right Hand 25.5 D L 60 D W
- Ozark Trail 12-Person 3-Room Instant Cabin Tent with Screen Room Camping Green
- All-Star System Seven Adult Baseball Catcher's Helmet - Scarlet
- NIKE MEN JORDAN 12 XII RETRO MCS BASEBALL CLEATS 854566-600 SZ 11.5 THESPOT917
- Intex LED Taschenlampe Deluxe 5 in 1 Multi 68691 .
- MAGLITE Industrial Handheld Light,Xenon,Red, TS6D036K
- Stiga Titanium 5.4 table tennis Blade, FL, New
- Rev-Changer Cobra Champagne-gold Bowling Wrist Supports Left Hand_EU
- COLUMBIA CONgreen Base TRX ski snow board pants, waterproof, breathable, womens M
- Adidas Adipro 18 Camiseta Portero Manga Larga green whiteo
- Esco helmet inner blueee EA998AX-2 2 sheets JAPAN
- Pacifique Sud - Poncho Surf - With Sleeves -100% Cotton
- Soccer shoes Football adidas Nemeziz Messi 17.4 FG CP9048 44
- Cressi Tecnica 3.5mm Wetsuit [4 L]
University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.
University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.
Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.
Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.
UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.